Polymyxin is a generic term for chemotherapeutic antibiotics elaborated in fermentations of various media by strains of Bacillus polymyxa (1). The known polymyxin polypeptides (A, B, C, D, and E) have closely similar chemical and biological properties, and have in common L-a, y-diaminobutyric acid, L-threonine and an unidentified C9 optically-active fatty acid. In addition to these acids, polymyxin A (aerosporin) contains D-leucine (2). Polymyxin A, first described by Ainsworth, Brown and Brownlee, was isolated by Brownlee and Bushby, and Catch and Friedmann (3) from broth cultures by adsorption onto a suitable carbon and elution with aqueous acetone containing sulfuric acid. Further purification was obtained by converting the antibiotic to the helianthate and subsequently to the hydrochloride. Polymyxin D, which is composed of the constituents of polymyxin A plus serine, was described by Benedict and Langlykke (4) and During the course of studies on polymyxin B designed to eliminate toxic impurities and prepare high potency material, a procedure was developed involving adsorption of the active principle on cotton sodium succinate, elution with dilute sulfuric acid, precipitation of the antibiotic with 1-(4-chloro-o-sulfophenyl)-5-hydroxy-3-1